Search Results
118 results found for "GREGORY TALL"
- GPCR News Flash! Top Updates You Can't-Miss! + University CheatSheet is finally available! ❄ Dec 2 - 8, 2024
Dive into our courses, talks, poster presentations, and more! announce that we've been working tirelessly to bring you a simple, beautiful, and insightful collection of all This is your last call before the curtain drops: Classified GPCR News is going VIP-only next year! That's right, all the tidbits below will be for Premium Members ' eyes only.
- Fly casting with ligand sliding and orientational selection supporting complex formation of a GPCR..
All molecular components (bosentan, hETB, membrane, and solvent) were represented with an all-atom model bosentan fluctuating randomly in solution is captured using a tip region of the flexible N-terminal tail Bosentan then slides occasionally from the tip to the root of the N-terminal tail (ligand–sliding). The bosentan-captured conformations by the tip-region and root-region of the N-terminal tail correspond
- 📰 GPCR Weekly News, September 11 to 17, 2023
If you have registered, please submit poster abstracts through this form and the short talk selections Targeted and Immuno-oncology Sosei Heptares Adds World-leading Expertise to its Scientific Advisory Board Call
- 📰 GPCR Weekly News, August 28 to September 3, 2023
You can submit your poster abstracts using this form and short talks will be selected from abstracts. Global Healthcare Conference CEO Raymond Stevens to Speak at STAT Future Summit on Obesity Therapeutics Call
- 📰 GPCR Weekly News, July 31 to August 6, 2023
Randy Hall's study: GPR37L1's role in shaping cortical astrocytes during development Dr. Research Collaboration Addex Therapeutics To Release Half-Year 2023 Financial Results And Host Conference Call
- 📰 GPCR Weekly News, February 20 to 26, 2023
All-Atom Molecular Dynamics Simulations Indicated the Involvement of a Conserved Polar Signaling Channel Slow-rising and fast-falling dopaminergic dynamics jointly adjust negative prediction error in the ventral understanding of the role of muscarinic receptors in the molecular pathology and treatment of schizophrenia Call
- Episode 87 of Dr. GPCR Podcast is available now!
Listen to her talk about her work and her transition to PI in Belfast.
- Trainees, this is for you...
Give a talk or present a poster at the Dr. GPCR Summit 2022.
- Join Us Now!
This is a great opportunity for us to come together and talk GPCRs. Do you want to be part of it? Our Summit is FREE for all Ecosystem site members, which is also free!
- 📰 GPCR Weekly News, January 15 to 21, 2024
The course covers basic pharmacology in four weekly segments and is open to all with a free site membership with advanced gastroenteropancreatic neuroendocrine tumors Neurocrine Biosciences Announces Conference Call rescue option for asthma GPCR Events, Meetings, and Webinars January 16 - 19, 2024 | 23rd Annual PEP Talk
- 📰 GPCR Weekly News, October 30 to November 4, 2023
Find speaker details on the Live Talks page and mark your calendar HERE. Progresses Its GLP-1 Receptor Agonist PF-06954522 into a Phase 1 Trial Andrew Hopkins Inducted into RSC BMCS Hall
- Navigating the Signaling Network: RTK and GPCR Crosstalk Uncovered
The cross-talk between growth factor receptors and GPCRs is an intriguing area of study. of specific phosphorylation events provide a deeper understanding of the molecular basis for cross-talk
- New structural perspectives in G protein-coupled receptor-mediated Src family kinase activation
Sandra Berndt talk about new structural perspectives in GPCR-mediated Src family kinase activation.
- Automated micro-plate-based methods for quantifying GPCR activation
Joe Clayton from BioTek Instruments talk about automated micro-plate-based methods for quantifying #GPCR
- Diversification of PAR signaling through receptor crosstalk
physiological and pathological relevance of these interactions, since this additional level of molecular cross-talk
- Time is your enemy, GPCRs are your friend
Come attend this month's virtual café talk to see the awesome work of Dr.
- 📰 GPCR Weekly News, May 15 to 21, 2023
We express our gratitude to the speakers for their excellent talks. If you are interested in giving a talk, contact us at Hello@DrGPCR.com, and if you would like to present
- Dr. Simone Promel
Join us for another virtual cafe talk to hear about the amazing work that Dr.
- GPR110, a receptor for synaptamide, expressed in osteoclasts negatively regulates osteoclastogenesis
GPR110 belongs to adhesion GPCR and was the functional receptor of N-docosahexaenoyl ethanolamine (also called
- Cholesterol occupies the lipid translocation pathway to block phospholipid scrambling by a GPCR
traverse a dynamically revealed hydrophilic groove between transmembrane helices (TM) 6 and 7 while their tails
- The Gluopsins: Opsins without the Retinal Binding Lysine
Thus, we call them gluopsins.
- Identification of GPCRs Modulating Flow-induced Signaling Pathways in Vascular Endothelial Cells
Join us for the first virtual cafe talk to hear about the amazing work that Dr.
- Discover the Hottest GPCR News of the Week: Oct 7-13, 2024!
Join us now, and let's explore with all our might! We aim to make education accessible to all! 🎉 We are bouncing off the walls with excitement to meet you all and geek out about GPCRs. Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Neurocrine Biosciences Announces Conference Call Webcast of Third Quarter 2024 Financial Results Novel full MC4 receptor-specific nanobody described Call
- 📰 GPCR Weekly News, November 6 to November 12, 2023
You can find more details about the speakers on the Live Talks page, and make sure to mark your calendar November 20 - 23, 2023 | ASCEPT Annual Scientific Meeting NEW January 16 - 19, 2024 | 23rd Annual PEP Talk
- Lipid Modulation of a Class B GPCR: Elucidating the Modulatory Role of PI(4,5)P 2 Lipids
We demonstrate how tail composition plays a role in modulating the binding of PI(4,5)P2 lipids to GCGR
- 📰 GPCR Weekly News, September 25 to October 1, 2023
You can find all the necessary information on the Logo Contest page. Did you know that as a premium member, you enjoy exclusive access to recorded talks from our Dr. Also, If you attended any of the talks, we'd truly value your feedback through our survey.
- Novel Therapies for Cardiometabolic Disease: Recent Findings in Studies with Hormone...
One successful strategy is the so-called metabolic surgery whose beneficial effects are beyond dietary
- First in Human: Early-stage COVID therapies hold promise against omicron variant
Sotrovimab is the first monoclonal antibody showing preclinical efficacy against all COVID-19 variants , including the delta and omicron mutations, Vir CEO George Scangos said on a Dec. 7 call with analysts